["{\"step_by_step_thinking\": \"The relevant documents discuss immunotherapy as an elegant treatment of IgE allergic inflammation in the airways. They also mention cytokines playing a role in the pathology of late-phase allergic responses and their potential use in diagnosis, prognosis, and/or monitoring of specific immunotherapy. Furthermore, the documents highlight the importance of understanding the underlying mechanisms of asthma to develop effective treatment plans. Given this information, it is inferred that dupilumab, which targets IL-4 and IL-13 cytokines implicated in allergic inflammation, may be an effective treatment for asthma.\", \"answer_choice\": \"A\"}"]